A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/20 (2006.01) A61K 9/28 (2006.01) A61K 31/137 (2006.01) A61K 31/445 (2006.01)
Patent
CA 2658170
Disclosed herein are controlled-release formulations which exhibit substantially zero-order release kinetics. The formulations include a core comprising a core active agent and a wax excipient substantially coated with an extended-release coating. The formulation optionally includes an immediate-release portion comprising an immediate-release active agent in the form of, for example, a coating disposed on at least a portion of the core. Further disclosed are fexofenadine/pseudoephedrine combination formulations, which exhibit substantially no food effect.
L'invention concerne des formulations à libération contrôlée qui présentent une cinétique de libération de l'ordre de sensiblement zéro. Les formulations comprennent un noyau incluant un agent actif de noyau et un excipient de cire, enrobé de façon substantielle par un enrobage à libération prolongée. La formulation comprend facultativement une partie à libération immédiate incluant un agent actif à libération immédiate, par exemple sous la forme d'un enrobage disposé sur au moins une partie du noyau. L'invention concerne en outre des formulations de combinaison fexofénadine/pseudoéphédrine, qui ne présentent pratiquement pas d'effet alimentaire.
Arnold Kristin
Nutalapati Siva Rama K.
Piya Ishari
Mutual Pharmaceutical Company Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Controlled-release formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled-release formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled-release formulations will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1433109